bornaprolol (FM 24)

structure

Also Known As:

FM 24; 1-(2-exo-bicyclo(2,2,1)hept-2-ylphenoxy)-3- ((1-methylethyl)amino)-2-propanol; FM-24; 2-Propanol, 1-(2-bicyclo(2.2.1)hept-2-ylphenoxy)-3-((1-methylethyl)amino)-

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Amino Alcohols: 20
    - Propanolamines: 4
      - bornaprolol: 8
- Alcohols: 595
  - Amino Alcohols: 20
    - Propanolamines: 4
      - bornaprolol: 8
  - Propanols: 3
    - Propanolamines: 4
      - bornaprolol: 8

Experts

1.	Choe, Yun Seon: 1 article (03/2017)
2.	Mun, Je-Ho: 1 article (03/2017)
3.	Ohn, Jungyoon: 1 article (03/2017)
4.	Park, Jin: 1 article (03/2017)
5.	Berrez, Stephane: 1 article (05/2014)
6.	Brousse, Eric: 1 article (05/2014)
7.	Marlot, Michel: 1 article (05/2014)
8.	Mauvieux, Benoit: 1 article (05/2014)
9.	Reinberg, Alain: 1 article (05/2014)
10.	Riedel, Marc: 1 article (05/2014)

Related Diseases

1.	Tachycardia (Tachyarrhythmias) 01/01/1985 - "In addition, exercise-induced tachycardia was significantly reduced by bornaprolol up to 48 hours after drug intake (pharmacodynamic half-life approximately 63-86 h) and there was a correlation between this reduction and the log plasma bornaprolol concentration over the 48-h period. " 06/01/1987 - "A correlation was also found for each group of subjects between the time course of the plasma drug concentration and the effects of each bornaprolol dose on isoproterenol- and exercise-induced tachycardia. " 01/01/1985 - "Bornaprolol significantly reduced resting heart rate, dose-dependently lowered exercise-induced tachycardia and decreased peak expiratory flow rate and plasma renin activity. " 06/01/1987 - "Bornaprolol significantly reduced the resting heart rate, isoproterenol- and exercise-induced tachycardia, and effort hypertension. "
2.	Asthma (Bronchial Asthma) 10/01/2000 - "Fifteen patients with atopic persistent asthma were evaluated (mean age, 32.4 years; FEV(1), 75.2% predicted) in a randomized, double-blind, double-dummy, placebo-controlled crossover study with a 1-week placebo washout period, comparing the following once-daily nighttime treatments: (1) formoterol (FM), 12 microg, for 2 weeks and FM, 24 microg, for 2 weeks; or (2) budesonide (BUD), 400 microg, for 2 weeks and BUD, 800 microg, for 2 weeks; or (3) FM, 12 microg, plus BUD, 400 microg, for 2 weeks and FM, 24 microg, plus BUD, 800 microg, for 2 weeks. " 07/01/1997 - "To investigate the facilitatory effects of acute administration of systemic corticosteroid on bronchodilator subsensitivity, as might occur in the setting of acute asthma, 12 subjects with moderately severe asthma, with a mean FEV1 of 66% predicted, of whom were all receiving inhaled corticosteriod, were randomized to receive either inhaled placebo (PL) or inhaled formoterol (FM) 24 micrograms twice daily for 4 wk in a double-blind crossover study. "
3.	Musculoskeletal Pain 08/01/2012 - "Thirty-six individuals with FM, 24 with local musculoskeletal pain, and 23 normal controls underwent testing of mechanical and heat hyperalgesia at the shoulders and hands. "
4.	Out-of-Hospital Cardiac Arrest 05/01/2014 - "We explored in a homogenous group of French firemen (FM) 24 h patterns of both lag time (LT) response duration to emergency calls for medical help (ECFM) for life-threatening out-of-hospital cardiac arrests (OHCA), used as a non-specific index of work performance, and WRI. "
5.	Nevus (Nevi) 03/01/2017 - "In all, 18 FM, 24 melanocytic activation of the nail matrix, 27 nail matrix nevi, and 11 malignant melanoma cases were analyzed. "

Related Drugs and Biologics

1.	Formoterol Fumarate (Oxis)
2.	Budesonide (Pulmicort)
3.	Renin
4.	Proteins (Proteins, Gene)
5.	Isoproterenol (Isoprenaline)
6.	Bronchodilator Agents (Bronchodilators)
7.	Adrenal Cortex Hormones (Corticosteroids)